AARTI PHARMALABS
Back to Cashflow Statement
|
AARTI PHARMALABS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹332 Cr | ₹216 Cr | ₹250 Cr | ₹-44 Cr | - |
What is the latest Cash Flow from Operating Activities ratio of AARTI PHARMALABS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹332 Cr |
| Mar2024 | ₹216 Cr |
| Mar2023 | ₹250 Cr |
| Mar2022 | ₹-44 Cr |
| Mar2021 | - |
How is Cash Flow from Operating Activities of AARTI PHARMALABS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹332 Cr | 53.25 | |
| Mar2024 | ₹216 Cr | -13.50 | |
| Mar2023 | ₹250 Cr | Positive | |
| Mar2022 | ₹-44 Cr | 0 | |
| Mar2021 | - | - | |
Compare Cash Flow from Operating Activities of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹7,729.0 Cr | 3.7% | 18.7% | 3.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | 3.7% |
18.7% |
3.8% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses